PQRS Measure
#67Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Performed on Bone Marrow
The following codes apply for this PQRS measure:
CPT Codes | |||
Code | Modifier | POS | Description |
---|---|---|---|
3155F | Cytogenetic testing performed on bone marrow at time of diagnosis or prior to initiating treatment (HEM) | ||
3155F | 8P | Cytogenetic testing performed on bone marrow at time of diagnosis or prior to initiating treatment (HEM) | |
3155F | 1P | Cytogenetic testing performed on bone marrow at time of diagnosis or prior to initiating treatment (HEM) | |
3155F | 2P | Cytogenetic testing performed on bone marrow at time of diagnosis or prior to initiating treatment (HEM) | |
3155F | 3P | Cytogenetic testing performed on bone marrow at time of diagnosis or prior to initiating treatment (HEM) | |
99201 | Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A problem focused history; A problem focused examination; Straightforward medical decision making. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are self limited or minor. Typically, 10 minutes are spent face-to-face with the patient and/or family. | ||
99202 | Office or other outpatient visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and straightforward medical decision making. When using total time on the date of the encounter for code selection, 15 minutes must be met or exceeded. | ||
99203 | Office or other outpatient visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and low level of medical decision making. When using total time on the date of the encounter for code selection, 30 minutes must be met or exceeded. | ||
99204 | Office or other outpatient visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and moderate level of medical decision making. When using total time on the date of the encounter for code selection, 45 minutes must be met or exceeded. | ||
99205 | Office or other outpatient visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and high level of medical decision making. When using total time on the date of the encounter for code selection, 60 minutes must be met or exceeded. | ||
99212 | Office or other outpatient visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and straightforward medical decision making. When using total time on the date of the encounter for code selection, 10 minutes must be met or exceeded. | ||
99213 | Office or other outpatient visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and low level of medical decision making. When using total time on the date of the encounter for code selection, 20 minutes must be met or exceeded. | ||
99214 | Office or other outpatient visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and moderate level of medical decision making. When using total time on the date of the encounter for code selection, 30 minutes must be met or exceeded. | ||
99215 | Office or other outpatient visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and high level of medical decision making. When using total time on the date of the encounter for code selection, 40 minutes must be met or exceeded. | ||
ICD9 Codes | |||
Code | Modifier | POS | Description |
204.00 | Acute lymphoid leukemia, without mention of having achieved remission | ||
204.02 | Acute lymphoid leukemia, in relapse | ||
205.00 | Acute myeloid leukemia, without mention of having achieved remission | ||
205.02 | Acute myeloid leukemia, in relapse | ||
206.00 | Acute monocytic leukemia, without mention of having achieved remission | ||
206.02 | Acute monocytic leukemia, in relapse | ||
207.00 | Acute erythremia and erythroleukemia, without mention of having achieved remission | ||
207.02 | Acute erythremia and erythroleukemia, in relapse | ||
207.20 | Megakaryocytic leukemia, without mention of having achieved remission | ||
207.22 | Megakaryocytic leukemia, in relapse | ||
208.00 | Acute leukemia of unspecified cell type, without mention of having achieved remission | ||
208.02 | Acute leukemia of unspecified cell type, in relapse | ||
238.72 | Low grade myelodysplastic syndrome lesions | ||
238.73 | High grade myelodysplastic syndrome lesions | ||
238.74 | Myelodysplastic syndrome with 5q deletion | ||
238.75 | Myelodysplastic syndrome, unspecified |
Legend:
Registry OKThis measure can be submitted through registry.
EHR OKThis measure can be submitted via Electronic Health Record (EHR).
More information on these alternative reporting mechanisms is available at:
http://www.cms.gov/PQRS/20_AlternativeReportingMechanisms.asp.
Registry OKThis measure can be submitted through registry.
EHR OKThis measure can be submitted via Electronic Health Record (EHR).
More information on these alternative reporting mechanisms is available at:
http://www.cms.gov/PQRS/20_AlternativeReportingMechanisms.asp.
Thank you for choosing Find-A-Code, please Sign In to remove ads.